what dose of bpc 157 is recommended BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage: A Complete Guide
Description
The irony was almost poetic
therefore, delivering the peptides via this N-to-B strategy is a potential alternative to the other CNS delivery strategies [9,16]
Another cause of LSS is when one of the bones of the spine slips forward over the one below it
Not recommended for individuals allergic to any B vitamins
